Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator Academic Article uri icon

Overview

MeSH Major

  • Anti-Arrhythmia Agents
  • Imidazolidines
  • Piperazines
  • Tachycardia, Ventricular

abstract

  • Azimilide significantly reduced the recurrence of VT or ventricular fibrillation terminated by shocks or ATP in ICD patients, thereby reducing the burden of symptomatic ventricular tachyarrhythmia.

publication date

  • December 14, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000149240.98971.A8

PubMed ID

  • 15533855

Additional Document Info

start page

  • 3646

end page

  • 54

volume

  • 110

number

  • 24